TAK logo

TAK Cash From Investing

Annual CFI:

-$2.53B+$848.51M(+25.13%)
March 31, 2025

Summary

  • As of today, TAK annual cash from investing is -$2.53 billion, with the most recent change of +$848.51 million (+25.13%) on March 31, 2025.
  • During the last 3 years, TAK annual cash from investing has fallen by -$708.39 million (-38.94%).
  • TAK annual cash from investing is now -168.38% below its all-time high of $3.70 billion, reached on March 31, 2021.

Performance

TAK Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTAKcash flow metrics

Quarterly CFI:

-$352.72M-$87.70M(-33.09%)
September 1, 2025

Summary

  • As of today, TAK quarterly cash from investing is -$352.72 million, with the most recent change of -$87.70 million (-33.09%) on September 1, 2025.
  • Over the past year, TAK quarterly cash from investing has increased by +$165.25 million (+31.90%).
  • TAK quarterly cash from investing is now -110.42% below its all-time high of $3.39 billion, reached on September 30, 2019.

Performance

TAK Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTAKcash flow metrics

TTM CFI:

-$1.59B+$165.25M(+9.44%)
September 1, 2025

Summary

  • As of today, TAK TTM cash from investing is -$1.59 billion, with the most recent change of +$165.25 million (+9.44%) on September 1, 2025.
  • Over the past year, TAK TTM cash from investing has increased by +$995.55 million (+38.57%).
  • TAK TTM cash from investing is now -142.51% below its all-time high of $3.73 billion, reached on March 31, 2021.

Performance

TAK TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTAKcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TAK Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+25.1%+31.9%+38.6%
3Y3 Years-38.9%-74.9%+11.9%
5Y5 Years-198.4%-238.2%-828.0%

TAK Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-38.9%+44.4%-154.0%+89.3%-6.5%+74.1%
5Y5-Year-168.4%+44.4%-112.6%+89.3%-142.5%+74.1%
All-TimeAll-Time-168.4%+90.2%-110.4%+97.5%-142.5%+93.9%

TAK Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$352.72M(-33.1%)
-$1.59B(+9.4%)
Jun 2025
-
-$265.02M(-90.9%)
-$1.75B(+30.5%)
Mar 2025
-$2.53B(+25.1%)
-$138.85M(+83.3%)
-$2.52B(+13.8%)
Dec 2024
-
-$829.34M(-60.1%)
-$2.92B(-13.3%)
Sep 2024
-
-$517.96M(+49.9%)
-$2.58B(-5.4%)
Jun 2024
-
-$1.03B(-90.7%)
-$2.45B(+27.3%)
Mar 2024
-$3.38B(+25.7%)
-$542.58M(-11.6%)
-$3.37B(+45.0%)
Dec 2023
-
-$486.27M(-25.7%)
-$6.13B(-2.6%)
Sep 2023
-
-$386.73M(+80.2%)
-$5.97B(-3.2%)
Jun 2023
-
-$1.96B(+40.7%)
-$5.79B(-26.8%)
Mar 2023
-$4.54B(-149.7%)
-$3.30B(-904.9%)
-$4.56B(-206.4%)
Dec 2022
-
-$328.35M(-62.8%)
-$1.49B(+17.3%)
Sep 2022
-
-$201.71M(+72.5%)
-$1.80B(+5.8%)
Jun 2022
-
-$734.16M(-226.0%)
-$1.91B(-4.7%)
Mar 2022
-$1.82B(-149.2%)
-$225.20M(+64.8%)
-$1.83B(-252.8%)
Dec 2021
-
-$638.98M(-104.1%)
$1.20B(-52.4%)
Sep 2021
-
-$313.14M(+51.7%)
$2.51B(-18.5%)
Jun 2021
-
-$648.39M(-123.2%)
$3.08B(-17.4%)
Mar 2021
$3.70B(+43.9%)
$2.80B(+312.4%)
$3.73B(+203.7%)
Dec 2020
-
$678.00M(+165.6%)
$1.23B(+818.9%)
Sep 2020
-
$255.24M(>+9900.0%)
-$170.89M(-105.8%)
Jun 2020
-
$1.65M(-99.4%)
$2.96B(+15.9%)
Mar 2020
$2.57B(+110.0%)
$293.60M(+140.7%)
$2.55B(+128.6%)
Dec 2019
-
-$721.38M(-121.3%)
-$8.94B(+60.5%)
Sep 2019
-
$3.39B(+939.1%)
-$22.63B(+12.6%)
Jun 2019
-
-$403.43M(+96.4%)
-$25.89B(-0.9%)
Mar 2019
-$25.65B(-2648.2%)
-$11.20B(+22.2%)
-$25.66B(-66.3%)
Dec 2018
-
-$14.41B(>-9900.0%)
-$15.42B(-1283.7%)
Sep 2018
-
$130.46M(+175.2%)
-$1.11B(+42.5%)
Jun 2018
-
-$173.58M(+82.2%)
-$1.94B(-109.0%)
Mar 2018
-$933.42M(+84.7%)
-$973.37M(-891.2%)
-$927.56M(+83.3%)
Dec 2017
-
-$98.20M(+85.8%)
-$5.57B(+3.4%)
Sep 2017
-
-$693.37M(-182.8%)
-$5.76B(-12.3%)
Jun 2017
-
$837.38M(+114.9%)
-$5.13B(+15.0%)
Mar 2017
-$6.11B(-850.5%)
-$5.61B(-1794.3%)
-$6.04B(-2679.2%)
Dec 2016
-
-$296.23M(-387.1%)
-$217.29M(+48.2%)
Sep 2016
-
-$60.82M(+13.5%)
-$419.20M(+20.8%)
Jun 2016
-
-$70.33M(-133.5%)
-$529.27M(+17.8%)
DateAnnualQuarterlyTTM
Mar 2016
-$642.54M(-195.2%)
$210.10M(+142.2%)
-$643.70M(+36.6%)
Dec 2015
-
-$498.14M(-191.5%)
-$1.01B(-626.5%)
Sep 2015
-
-$170.89M(+7.5%)
$192.73M(-39.5%)
Jun 2015
-
-$184.76M(-14.8%)
$318.61M(-58.7%)
Mar 2015
$674.71M(+142.6%)
-$160.98M(-122.7%)
$771.02M(-17.3%)
Dec 2014
-
$709.36M(+1676.1%)
$931.99M(+318.6%)
Sep 2014
-
-$45.01M(-116.8%)
$222.64M(-16.8%)
Jun 2014
-
$267.64M(+439.2%)
$267.64M(+122.9%)
Mar 2014
-$1.58B(-0.2%)
-
-
Mar 2013
-$1.58B(+88.6%)
-
-
Mar 2012
-$13.85B(-1095.4%)
-
-
Mar 2011
-$1.16B(+8.4%)
-$78.89M(+79.1%)
-$1.17B(+32.0%)
Dec 2010
-
-$377.85M(+21.3%)
-$1.72B(-9.0%)
Sep 2010
-
-$480.29M(-106.5%)
-$1.58B(-23.7%)
Jun 2010
-
-$232.56M(+63.1%)
-$1.28B(-0.2%)
Mar 2010
-$1.27B(+83.4%)
-$630.38M(-166.9%)
-$1.27B(-97.8%)
Dec 2009
-
-$236.19M(-33.0%)
-$644.27M(-57.9%)
Sep 2009
-
-$177.54M(+23.0%)
-$408.08M(-77.0%)
Jun 2009
-
-$230.54M
-$230.54M
Mar 2009
-$7.63B(-956.9%)
-
-
Mar 2008
$890.28M(-10.6%)
-
-
Mar 2007
$995.56M(+1616.2%)
-
-
Mar 2006
$58.01M(+108.6%)
-
-
Mar 2005
-$672.67M(+45.4%)
-
-
Mar 2004
-$1.23B(-207.2%)
-
-
Mar 2003
$1.15B(+14.7%)
-
-
Mar 2002
$1.00B(+290.3%)
-
-
Mar 2001
-$526.74M(-13.5%)
-
-
Mar 2000
-$464.03M(+65.2%)
-
-
Mar 1999
-$1.33B(-124.9%)
-
-
Mar 1998
-$592.35M(-48.4%)
-
-
Mar 1997
-$399.05M(+14.0%)
-
-
Mar 1996
-$463.90M(+21.3%)
-
-
Mar 1995
-$589.34M(-56.5%)
-
-
Mar 1994
-$376.52M(-66.5%)
-
-
Mar 1993
-$226.11M(+1.9%)
-
-
Mar 1992
-$230.46M(+10.4%)
-
-
Mar 1991
-$257.11M
-
-

FAQ

  • What is Takeda Pharmaceutical Company Limited annual cash from investing?
  • What is the all-time high annual cash from investing for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited annual cash from investing year-on-year change?
  • What is Takeda Pharmaceutical Company Limited quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited quarterly cash from investing year-on-year change?
  • What is Takeda Pharmaceutical Company Limited TTM cash from investing?
  • What is the all-time high TTM cash from investing for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited TTM cash from investing year-on-year change?

What is Takeda Pharmaceutical Company Limited annual cash from investing?

The current annual cash from investing of TAK is -$2.53B

What is the all-time high annual cash from investing for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high annual cash from investing is $3.70B

What is Takeda Pharmaceutical Company Limited annual cash from investing year-on-year change?

Over the past year, TAK annual cash from investing has changed by +$848.51M (+25.13%)

What is Takeda Pharmaceutical Company Limited quarterly cash from investing?

The current quarterly cash from investing of TAK is -$352.72M

What is the all-time high quarterly cash from investing for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high quarterly cash from investing is $3.39B

What is Takeda Pharmaceutical Company Limited quarterly cash from investing year-on-year change?

Over the past year, TAK quarterly cash from investing has changed by +$165.25M (+31.90%)

What is Takeda Pharmaceutical Company Limited TTM cash from investing?

The current TTM cash from investing of TAK is -$1.59B

What is the all-time high TTM cash from investing for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high TTM cash from investing is $3.73B

What is Takeda Pharmaceutical Company Limited TTM cash from investing year-on-year change?

Over the past year, TAK TTM cash from investing has changed by +$995.55M (+38.57%)
On this page